Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5

Biological Psychiatry

Volumn 76, Issue 10, 2014, Pages 767-774

  Glück, Laura ^a   Loktev, Anastasia ^a   Moulédous, Lionel ^b   Mollereau, Catherine ^b   Law, Ping Yee ^c   Schulz, Stefan ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bar code; Conditioned place preference; Dependence; G protein coupled receptor kinase; Mu opioid receptor; Phosphorylation

Indexed keywords

ETONITAZENE; FENTANYL; G PROTEIN COUPLED RECEPTOR KINASE 5; MORPHINE; MU OPIATE RECEPTOR; SERINE; THREONINE; ADRBK2 PROTEIN, MOUSE; BENZIMIDAZOLE DERIVATIVE; G PROTEIN COUPLED RECEPTOR KINASE 3; GPRK5 PROTEIN, MOUSE; ISOPROTEIN; NARCOTIC ANALGESIC AGENT;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONDITIONED PLACE PREFERENCE TEST; HOT PLATE TEST; IMMUNOPRECIPITATION; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MORPHINE TOLERANCE; MOUSE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TANDEM MASS SPECTROMETRY; AGONISTS; ANIMAL; CONDITIONING; DRUG EFFECTS; DRUG TOLERANCE; ENZYMOLOGY; GENE INACTIVATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MORPHINE ADDICTION; NOCICEPTION; PHOSPHORYLATION; PHYSIOLOGY; REWARD;

ANALGESICS, OPIOID; ANIMALS; BENZIMIDAZOLES; CONDITIONING (PSYCHOLOGY); DRUG TOLERANCE; FENTANYL; G-PROTEIN-COUPLED RECEPTOR KINASE 3; G-PROTEIN-COUPLED RECEPTOR KINASE 5; GENE KNOCKOUT TECHNIQUES; MICE; MICE, KNOCKOUT; MORPHINE; MORPHINE DEPENDENCE; NOCICEPTION; PHOSPHORYLATION; PROTEIN ISOFORMS; RECEPTORS, OPIOID, MU; REWARD;

EID: 84927909882     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.01.021     Document Type: Article

References (56)

1. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, et al. (1996): Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383:819-823
2. Connor M, Osborne PB, Christie MJ (2004): Mu-opioid receptor desensitization: Is morphine different? Br J Pharmacol 143:685-696
3. Koch T, Hollt V (2008): Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther 117:199-206
4. Doll C, Konietzko J, Poll F, Koch T, Hollt V, Schulz S (2011): Agonistselective patterns of micro-opioid receptor phosphorylation revealed by phosphosite-specific antibodies. Br J Pharmacol 164:298-307
5. Just S, Illing S, Trester-Zedlitz M, Lau EK, Kotowski SJ, Miess E, et al. (2013): Differentiation of opioid drug effects by hierarchical multi-site phosphorylation. Mol Pharmacol 83:633-639
6. Doll C, Poll F, Peuker K, Loktev A, Gluck L, Schulz S (2012): Deciphering micro-opioid receptor phosphorylation and dephosphorylation in HEK293 cells. Br J Pharmacol 167:1259-1270
7. Schulz S, Mayer D, Pfeiffer M, Stumm R, Koch T, Hollt V (2004): Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J 23:3282-3289
8. McPherson J, Rivero G, Baptist M, Llorente J, Al-Sabah S, Krasel C, et al. (2010): Mu-opioid receptors: Correlation of agonist efficacy for signalling with ability to activate internalization. Mol Pharmacol 78:756-766
9. Premont RT, Gainetdinov RR (2007): Physiological roles of G proteincoupled receptor kinases and arrestins. Annu Rev Physiol 69:511-534
10. Gainetdinov RR, Premont RT, Caron MG, Lefkowitz RJ (2000): Receptor specificity of G-protein-coupled receptor kinases. Trends Pharmacol Sci 21:366-367
11. Loudon RP, Perussia B, Benovic JL (1996): Differentially regulated expression of the G-protein-coupled receptor kinases, betaARK and GRK6, during myelomonocytic cell development in vitro. Blood 88:4547-4557
12. Schleicher S, Boekhoff I, Arriza J, Lefkowitz RJ, Breer H (1993): A betaadrenergic receptor kinase-like enzyme is involved in olfactory signal termination. Proc Natl Acad Sci U S A 90:1420-1424
13. Premont RT, Macrae AD, Stoffel RH, Chung N, Pitcher JA, Ambrose C, et al. (1996): Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J Biol Chem 271:6403-6410
14. Sallese M, Mariggio S, Collodel G, Moretti E, Piomboni P, Baccetti B, et al. (1997): G protein-coupled receptor kinase GRK4. Molecular analysis of the four isoforms and ultrastructural localization in spermatozoa and germinal cells. J Biol Chem 272:10188-10195
15. Terman GW, Jin W, Cheong YP, Lowe J, Caron MG, Lefkowitz RJ, et al. (2004): G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br J Pharmacol 141:55-64
16. Melief EJ, Miyatake M, Bruchas MR, Chavkin C (2010): Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc Natl Acad Sci U S A 107:11608-11613
17. Raehal KM, Schmid CL, Medvedev IO, Gainetdinov RR, Premont RT, Bohn LM (2009): Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6. Drug Alcohol Depend 104:187-196
18. Lupp A, Richter N, Doll C, Nagel F, Schulz S (2011): UMB-3, a novel rabbit monoclonal antibody, for assessing mu-opioid receptor expression in mouse, rat and human formalin-fixed and paraffin-embedded tissues. Regul Pept 167:9-13
19. Grecksch G, Just S, Pierstorff C, Imhof AK, Gluck L, Doll C, et al. (2011): Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A mu-opioid receptor knock-in mice. J Neurosci 31:13890-13896
20. Busillo JM, Armando S, Sengupta R, Meucci O, Bouvier M, Benovic JL (2010): Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J Biol Chem 285:7805-7817
21. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, NC3Rs Reporting Guidelines Working Group (2010): Animal research: Reporting in vivo experiments: The ARRIVE guidelines. Br J Pharmacol 160:1577-1579
22. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL (2010): Guidelines for reporting experiments involving animals: The ARRIVE guidelines. Br J Pharmacol 160:1573-1576
23. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borrelli E (1997): Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388:586-589
24. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ (2012): Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179-197
25. Ren XR, Reiter E, Ahn S, Kim J, Chen W, Lefkowitz RJ (2005): Different G protein-coupled receptor kinases govern G protein and beta-arrestinmediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci U S A 102:1448-1453
26. Kim J, Ahn S, Ren XR, Whalen EJ, Reiter E, Wei H, et al. (2005): Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci U S A 102:1442-1447
27. Kara E, Crepieux P, Gauthier C, Martinat N, Piketty V, Guillou F, et al. (2006): A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation. Mol Endocrinol 20:3014-3026
28. Reiter E, Lefkowitz RJ (2006): GRKs and beta-arrestins: Roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17:159-165
29. Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, et al. (2006): Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 281:1261-1273
30. Butcher AJ, Prihandoko R, Kong KC, McWilliams P, Edwards JM, Bottrill A, et al. (2011): Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code. J Biol Chem286:11506-11518
31. Nobles KN, Xiao K, Ahn S, Shukla AK, Lam CM, Rajagopal S, et al. (2011): Distinct phosphorylation sites on the beta(2)-adrenergic receptor establish a barcode that encodes differential functions of beta-arrestin. Sci Signal 4:ra51
32. Heitzler D, Durand G, Gallay N, Rizk A, Ahn S, Kim J, et al. (2012): Competing G protein-coupled receptor kinases balance G protein and beta-arrestin signaling. Mol Syst Biol 8:590
33. Gainetdinov RR, Bohn LM, Walker JK, Laporte SA, Macrae AD, Caron MG, et al. (1999): Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron 24:1029-1036
34. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT (1999): Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495-2498
35. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG (2000): Muopioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720-723
36. Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, et al. (2003): Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci 23: 10265-10273
37. Raehal KM, Bohn LM (2011): The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics. Neuropharmacology 60:58-65
38. Haberstock-Debic H, Wein M, Barrot M, Colago EE, Rahman Z, Neve RL, et al. (2003): Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J Neurosci 23: 4324-4332
39. Koob GF (1992): Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184
40. Steketee JD, Sorg BA, Kalivas PW (1992): The role of the nucleus accumbens in sensitization to drugs of abuse. Prog Neuropsychopharmacol Biol Psychiatry 16:237-246
41. Lintas A, Chi N, Lauzon NM, Bishop SF, Gholizadeh S, Sun N, et al. (2011): Identification of a dopamine receptor-mediated opiate reward memory switch in the basolateral amygdala-nucleus accumbens circuit. J Neurosci 31:11172-11183
42. Ford CP, Mark GP, Williams JT (2006): Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 26:2788-2797
43. Chen Y, Wang F, Long H, Chen Y, Wu Z, Ma L (2011): GRK5 promotes F-actin bundling and targets bundles to membrane structures to control neuronal morphogenesis. J Cell Biol 194:905-920
44. Valjent E, Corbille AG, Bertran-Gonzalez J, Herve D, Girault JA (2006): Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc Natl Acad Sci U S A 103:2932-2937
45. Gong YX, Zhang WP, Shou WT, Zhong K, Chen Z (2010): Morphine induces conditioned place preference behavior in histidine decarboxylase knockout mice. Neurosci Lett 468:115-119
46. Bouton ME (1993): Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull 114:80-99
47. Miller CA, Marshall JF (2005): Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 47: 873-884
48. Wang WS, Kang S, Liu WT, Li M, Liu Y, Yu C, et al. (2012): Extinction of aversive memories associated with morphine withdrawal requires ERK-mediated epigenetic regulation of brain-derived neurotrophic factor transcription in the rat ventromedial prefrontal cortex. J Neurosci 32:13763-13775
49. Eitan S, Bryant CD, Saliminejad N, Yang YC, Vojdani E, Keith D Jr, et al. (2003): Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J Neurosci 23:8360-8369
50. Valjent E, Pages C, Herve D, Girault JA, Caboche J (2004): Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 19:1826-1836
51. Macey TA, Lowe JD, Chavkin C (2006): Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons. J Biol Chem 281:34515-34524
52. West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz AJ, et al. (2001): Calcium regulation of neuronal gene expression. Proc Natl Acad Sci U S A 98:11024-11031
53. Funada M, Suzuki T, Narita M, Misawa M, Nagase H (1993): Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 32:1315-1323
54. Glick SD, Maisonneuve IM, Raucci J, Archer S (1995): Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681:147-152
55. Kuzmin AV, Semenova S, Gerrits MA, Zvartau EE, Van Ree JM (1997): Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur J Pharmacol 321:265-271
56. Wee S, Koob GF (2010): The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology 210:121-135